Research compound supplied in Australia by Pulse Biolabs for laboratory use. Available in 10mg, 15mg.
DSIP was isolated in 1977 from rabbits in induced slow-wave sleep. Nearly fifty years on, the name is still the strongest claim made about it, and the small human trials disagree.
DSIP, delta sleep-inducing peptide, is a nine-amino-acid peptide isolated in 1977 from the blood of rabbits in induced slow-wave sleep. It is studied for whether it acts as a sleep-related signal, a question that remains open because no gene or receptor for it has been identified. Evidence comes from animal EEG studies and a few small intravenous trials in adults with chronic insomnia and in healthy volunteers, with conflicting conclusions.
Read the full research note →| Presentation | Code | Status | Price |
|---|---|---|---|
| 10mg | DSIP10 | Sold out | $75 |
| 15mg | DSIP15 | In stock | $100 |
No batch-specific test report is currently published for this product. What a report does and does not show.
Supplied as lyophilised (freeze-dried) powder in a sealed vial. Store sealed and protected from light at the conditions stated on the product label or supplied specification. Solvent choice, concentration and handling after reconstitution depend on the compound and on the laboratory’s own procedures, and are not specified here.
DSIP is not an approved medicine in Australia. No regulator-approved DSIP medicine was identified in any jurisdiction for this note.
Status checked 2026-09-23. Details and sources in the research note.